Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001311044 | SCV000521963 | benign | not provided | 2021-10-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460308 | SCV000554328 | benign | Intellectual disability, autosomal dominant 8 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313066 | SCV000849303 | likely benign | Inborn genetic diseases | 2015-12-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001311044 | SCV001501070 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | GRIN1: BP4, BP7 |
Genetic Services Laboratory, |
RCV001821173 | SCV002072283 | benign | not specified | 2017-11-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001311044 | SCV005228754 | likely benign | not provided | criteria provided, single submitter | not provided |